Table 4 Harm reduction practices among PWID with comparison by drug co-use
Characteristic | Overall, N = 534 | Opioids & stimulants, N = 220 | Opioids only, N = 104 | Stimulants only, N = 210 | p-value |
|---|---|---|---|---|---|
Interested in treatment/detox, n (%) | 79 (14.8%) | 47 (21.4%) | 18 (17.3%) | 14 (6.7%) | < 0.0011 |
Ever used naloxone, n (%) | 214 (40.1%) | 132 (60.0%) | 45 (43.3%) | 37 (17.6%) | < 0.0011 |
Interested in naloxone education, n (%) | 154 (28.8%) | 71 (32.3%) | 33 (31.7%) | 50 (23.8%) | 0.121 |
Want to obtain naloxone, n (%) | 296 (55.4%) | 153 (69.5%) | 61 (58.7%) | 82 (39.0%) | < 0.0011 |
Rapid HCV test wanted, n (%) | 73 (13.7%) | 33 (15.0%) | 14 (13.5%) | 26 (12.4%) | 0.71 |
HCV medical referral wanted, n (%) | 22 (4.1%) | 15 (6.8%) | 5 (4.8%) | 2 (1.0%) | 0.0042 |
Rapid HIV test wanted, n (%) | 84 (15.7%) | 44 (20.0%) | 10 (9.6%) | 30 (14.3%) | 0.0431 |
HIV medical referral wanted, n (%) | 5 (0.9%) | 1 (0.5%) | 0 (0.0%) | 4 (1.9%) | 0.22 |
Referral for STD testing wanted, n (%) | 73 (13.7%) | 38 (17.3%) | 8 (7.7%) | 27 (12.9%) | 0.0581 |